Single-nucleotide polymorphisms and their role in coronary artery disease: Where do we stand now?

被引：4
|
作者：
Papageorgiou, Nikolaos [1 ]
Tousoulis, Dimitris [2 ]
机构：
[1] St Bartholomews Hosp, Barts Heart Ctr, London EC1A 7BE, England
[2] Hippokrateion Hosp, Cardiol Dept 1, Athens, Greece
来源：
HELLENIC JOURNAL OF CARDIOLOGY | 2018年 / 59卷 / 01期
关键词：
FIBRINOGEN GENETIC-VARIABILITY; MENDELIAN RANDOMIZATION; MYOCARDIAL-INFARCTION; FATTY LIVER; ACUTE-PHASE; ASSOCIATION; RISK; ATHEROSCLEROSIS; PROTEIN; ERAD;
D O I：
10.1016/j.hjc.2018.02.013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：14 / 15
页数：2
相关论文
共 50 条
  • [31] Laparoscopic Adrenalectomy: Where Do We Stand Now?
    Karanikola, Evridiki
    Tsigris, Christos
    Kontzoglou, Konstantinos
    Nikiteas, Nikolaos
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 220 (04): : 259 - 265
  • [32] HRT 2004: Where do we stand now
    Pines, A
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2004, 6 (10): : 642 - 643
  • [33] HDL Hypothesis: Where Do We Stand Now?
    Sayed M. Tariq
    Mandeep S. Sidhu
    Peter P. Toth
    William E. Boden
    Current Atherosclerosis Reports, 2014, 16
  • [34] The 'oestrogen hypothesis' - where do we stand now?
    Sharpe, RM
    INTERNATIONAL JOURNAL OF ANDROLOGY, 2003, 26 (01): : 2 - 15
  • [35] An insight into iTRAQ: where do we stand now?
    Caroline Evans
    Josselin Noirel
    Saw Yen Ow
    Malinda Salim
    Ana G. Pereira-Medrano
    Narciso Couto
    Jagroop Pandhal
    Duncan Smith
    Trong Khoa Pham
    Esther Karunakaran
    Xin Zou
    Catherine A. Biggs
    Phillip C. Wright
    Analytical and Bioanalytical Chemistry, 2012, 404 : 1011 - 1027
  • [36] Biologics in vasculitides: Where do we stand, where do we go from now?
    Pazzola, Giulia
    Muratore, Francesco
    Pipitone, Nicolo
    Salvarani, Carlo
    PRESSE MEDICALE, 2015, 44 (06): : E231 - E239
  • [37] Coronary artery fistula, where are we now?
    Benetti, Federico
    Gonzalez, Jessica
    Abuin, Gustavo
    JOURNAL OF CARDIAC SURGERY, 2021, 36 (12) : 4623 - 4624
  • [38] Single-nucleotide polymorphisms in inflammatory bowel disease
    Neuman, Manuela G.
    Nanau, Radu M.
    TRANSLATIONAL RESEARCH, 2012, 160 (01) : 45 - 64
  • [39] Low Dose CT: Where Do We Stand Now?
    Leng, Shuai
    Chen, G.
    Stayman, J.
    McCollough, C.
    Pickhardt, P.
    MEDICAL PHYSICS, 2017, 44 (06) : 3248 - 3249
  • [40] Antioxidants and CVD in diabetes: Where do we stand now?
    Yim S.
    Malhotra A.
    Veves A.
    Current Diabetes Reports, 2007, 7 (1) : 8 - 13
12345